Overcoming Bottlenecks and Exploring the Future of Lentiviral and Adenoviral Vectors
Source: Cell & Gene
In this Cell & Gene Live, Advancing Gene Delivery: LNPs, Adenovirus, Lentivirus, And More, Francesca Barone, M.D., Ph.D., CSO at Candel Therapeutics provides insights on a novel multimodal immunotherapy showing strong results in prostate cancer. A must-watch for anyone exploring next-gen vector innovation in CGT.
access the Video!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.
Subscribe to Cell & Gene
X
Subscribe to Cell & Gene